Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 10,019 Shares

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 10,019 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $6.02, for a total transaction of $60,314.38. Following the sale, the director directly owned 557,990 shares in the company, valued at $3,359,099.80. This trade represents a 1.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Robin Shane Readnour also recently made the following trade(s):

• On Thursday, September 3rd, Robin Shane Readnour sold 6,100 shares of Anthem stock. The shares were sold at an average price of $6.07, for a total transaction of $37,027.00.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total transaction of $212,766.02.

Anthem Trading Up 1.5%

Shares of Anthem stock traded up $0.09 during trading on Tuesday, hitting $5.98. The stock had a trading volume of 335,287 shares, compared to its average volume of 213,148. The firm has a market cap of $225.69 million, a price-to-earnings ratio of -5.59 and a beta of -0.99. Anthem, Inc. has a 12 month low of $1.00 and a 12 month high of $7.19. The business’s 50-day moving average is $5.33 and its 200 day moving average is $4.41.

Anthem (NASDAQ:ANTX) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) earnings per share (EPS) for the quarter.

Institutional Investors Weigh In On Anthem

Institutional investors have recently bought and sold shares of the stock. Citizens Financial Group Inc. RI purchased a new position in Anthem in the 2nd quarter worth approximately $1,443,000. ADAR1 Capital Management LLC purchased a new stake in shares of Anthem during the first quarter valued at approximately $47,000. OMERS ADMINISTRATION Corp bought a new position in shares of Anthem in the first quarter worth approximately $54,000. Velan Capital Investment Management LP bought a new position in shares of Anthem in the second quarter worth approximately $194,000. Finally, Seven Fleet Capital Management LP purchased a new position in shares of Anthem in the first quarter worth $683,000. 90.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Guggenheim started coverage on shares of Anthem in a research note on Monday, July 20th. They issued a “buy” rating and a $9.00 target price on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Anthem in a research note on Monday, July 6th. Leerink Partners upgraded Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective for the company in a report on Thursday, May 14th. Finally, Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $9.00.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.